Share on Instagram  
Background Image

#iconohash presents #PhdChat

Scroll down for the #PhdChat conversation report for July 4th, 2022 EST.

iconohash

the world's conversation archive

#PhdChat for July 4th, 2022 EST

01
1st

coming together

When it comes to participants, we ranked 1st among 120 conversations.

1st

participating

In terms of the number of posts, we ranked 1st out of 120 conversations that took place.

1st

amplification

This conversation ranked 1st out of 120 in terms of the amplification of ideas & content.

how we participated. Here's how participants reacted & engaged each other

Reactions
87%

Amplified

There were 323 reshares, 87% of posts, during the course of the conversation.

0%

Engaged

0% of participants in this conversation engaged each other 1 times.

8%

Content

8% of participants in this conversation shared a total of 6 unique pieces of content.

quick facts.

Here are the basic facts of the conversation for for July 4th, 2022.

0
Active
Participants
0
Posts
Total

meet the influencers the movers and shakers of #PhdChat

02

the top of the list. Top influencers in the chat

IMPACT
@kwamigh

@kwamigh

kwami Ahiabenu,II
Kwami Ahiabenu,II consultant and trainer

@vibhorpande

@vibhorpande

Vib
Part-time Data Culturist full-time Flâneur

@ComicResearch1

@ComicResearch1

Research and Comics
This account is purely made for people who are doing research or associated or stuck somewhere inside research. fun time doctors.

about the participants. let's take a look at everyone who show'd up

03

top professions what are they doing when they're not in #PhdChat

insight

  the top participating professions
out of 46 total

research
professor
writer
academic
engineering

gender an estimation of what the gender break down looks like
= 1 men or women

insight

Women

Men

about the content. the best content that was shared

04
Frontiers | Translating MSC Therapy in the Age of Obesity
Mesenchymal stromal cell (MSC) therapy has seen increased attention as a possible option to treat a number of inflammatory conditions including COVID-19 acute respiratory distress syndrome (ARDS). As rates of obesity and metabolic disease continue to rise worldwide, increasing proportions of patients treated with MSC therapy will be living with obesity. The obese environment poses critical challenges for immunomodulatory therapies that should be accounted for during development and testing of MS

chat growth how is #PhdChat growing over time?

05

want more? are you interested in the full data analysis for this chat? Full transcript? Longer view at chat growth?

Order Report

Order a report now or request a custom report by emailing your request to research@iconohash.com. We'll be happy to work with you. We can provide the raw data or custom reports on a scheduled basis. Full data analysis includes in-depth profile data, chat growth analysis, chat reach, influence reach, location profiles, and content profiles.